Construction and validation of a TP53-associated immune prognostic model for gastric cancer
Kechao Nie(Guangzhou University of Chinese Medicine), Peiwu Li(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Zhitong Deng(Guangzhou University of Chinese Medicine), Kailin Jiang(Guangzhou University of Chinese Medicine), Laner Shi(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Jinglin Pan(Hainan Provincial Hospital of Traditional Chinese Medicine), Xiushen Li(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Kunhai Zhuang(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Wei Huang(Central South University), Yanhua Yan(Guangzhou University of Chinese Medicine), Bin Fu(Central South University), Yi Wen(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Xiaotao Jiang(Guangzhou University of Chinese Medicine), Yingsheng Zhou(Chinese University of Hong Kong, Shenzhen), Fengbin Liu(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Zhihua Zheng(Sun Yat-sen University), Xueqi Wang(Xiyuan Hospital), Shjie Xu(Guangzhou University of Chinese Medicine)
Cited by 34
Related Papers
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases
|Leukemia Research|2014|128
Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution
|American Journal of Hematology|2014|83
Construction and Validation of a Ferroptosis-Related Prognostic Model for Gastric Cancer
|Journal of Oncology|2021|52
Relationship between long‐term use of proton pump inhibitors and risk of gastric cancer: A systematic analysis
|Journal of Gastroenterology and Hepatology|2019|44